Dolby Laboratories Inc. (NYSE:DLB) CFO Lewis Chew sold 15,000 shares of the firm’s stock in a transaction dated Monday, November 21st. The stock was sold at an average price of $46.85, for a total value of $702,750.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.

Lewis Chew also recently made the following trade(s):

  • On Monday, August 29th, Lewis Chew sold 12,000 shares of Dolby Laboratories stock. The stock was sold at an average price of $49.79, for a total value of $597,480.00.

Dolby Laboratories Inc. (NYSE:DLB) opened at 46.94 on Thursday. Dolby Laboratories Inc. has a 1-year low of $30.38 and a 1-year high of $55.02. The firm has a 50-day moving average price of $49.28 and a 200-day moving average price of $49.04. The company has a market capitalization of $4.82 billion, a P/E ratio of 25.93 and a beta of 0.64.

Dolby Laboratories (NYSE:DLB) last announced its quarterly earnings data on Wednesday, October 26th. The company reported $0.37 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.20 by $0.17. The company had revenue of $233 million for the quarter, compared to the consensus estimate of $226.45 million. Dolby Laboratories had a return on equity of 9.87% and a net margin of 18.12%. The firm’s revenue was up .1% compared to the same quarter last year. During the same period in the previous year, the business earned $0.43 EPS. On average, analysts forecast that Dolby Laboratories Inc. will post $1.99 EPS for the current fiscal year.

Insider Buying and Selling by Quarter for Dolby Laboratories (NYSE:DLB)

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, November 16th. Stockholders of record on Monday, November 7th were paid a $0.14 dividend. This represents a $0.56 dividend on an annualized basis and a dividend yield of 1.19%. This is an increase from Dolby Laboratories’s previous quarterly dividend of $0.12. The ex-dividend date was Thursday, November 3rd. Dolby Laboratories’s payout ratio is currently 30.94%.

DLB has been the topic of a number of research analyst reports. Dougherty & Co raised their price target on Dolby Laboratories from $54.00 to $57.00 and gave the stock a “buy” rating in a research report on Thursday, July 28th. B. Riley set a $50.00 price objective on Dolby Laboratories and gave the stock a “hold” rating in a report on Thursday, July 28th. JPMorgan Chase & Co. initiated coverage on Dolby Laboratories in a report on Tuesday, October 4th. They set a “neutral” rating and a $51.00 price objective for the company. Barrington Research upgraded Dolby Laboratories from a “market perform” rating to an “outperform” rating in a report on Thursday, October 27th. Finally, Zacks Investment Research downgraded Dolby Laboratories from a “hold” rating to a “strong sell” rating in a report on Friday, October 28th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and four have assigned a buy rating to the company’s stock. Dolby Laboratories has a consensus rating of “Hold” and a consensus target price of $50.60.

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Walleye Trading LLC increased its position in shares of Dolby Laboratories by 155.8% in the second quarter. Walleye Trading LLC now owns 2,122 shares of the company’s stock worth $102,000 after buying an additional 5,922 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its position in shares of Dolby Laboratories by 10.3% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,122 shares of the company’s stock worth $115,000 after buying an additional 199 shares in the last quarter. BNP Paribas Arbitrage SA increased its position in shares of Dolby Laboratories by 13.9% in the second quarter. BNP Paribas Arbitrage SA now owns 2,901 shares of the company’s stock worth $139,000 after buying an additional 353 shares in the last quarter. US Bancorp DE increased its position in shares of Dolby Laboratories by 17.2% in the second quarter. US Bancorp DE now owns 3,138 shares of the company’s stock worth $150,000 after buying an additional 460 shares in the last quarter. Finally, The Manufacturers Life Insurance Company acquired a new position in shares of Dolby Laboratories during the third quarter worth about $156,000. 50.95% of the stock is currently owned by institutional investors.

COPYRIGHT VIOLATION WARNING: This report was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this report on another domain, it was copied illegally and reposted in violation of U.S. & international trademark & copyright legislation. The correct version of this report can be viewed at https://www.thecerbatgem.com/2016/11/24/lewis-chew-sells-15000-shares-of-dolby-laboratories-inc-dlb-stock.html.

About Dolby Laboratories

Dolby Laboratories, Inc creates audio, imaging and communication technologies that transform entertainment and communications at the cinema, home, work and on mobile devices. The Company offers digital signal processing and compression technologies. Its technologies enable the development of the audio technologies for the cinema, home entertainment, mobile and gaming experiences.

5 Day Chart for NYSE:DLB

Receive News & Stock Ratings for Dolby Laboratories Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories Inc. and related stocks with our FREE daily email newsletter.